Adherium, a New Zealand-based maker of connected respiratory medical devices, has received the US Food and Drug Administration's 510(k) clearance for connecting its digital monitoring platform with GlaxoSmithKline’s range of Ellipta dry powder inhalers.
The ASX-listed firm offers the Hailie sensor which attaches to an inhaler to remotely monitor and capture medication usage parameters and...
Jerusalem-based Teva Pharmaceuticals announced this week the U.S. launch of its ProAir Digihaler.
The sensor-laden albuterol dispenser requires a prescription, and is indicated for those aged four years or older with reversible obstructive airway diseases such as asthma and COPD, as well as for the prevention of exercise-induced bronchospasm (EIB) among this same group.
The device connects to a...
Alphabet serious about health wearables? Alphabet has reportedly put in an unspecified offer to buy out Fitbit, according to anonymous sources talking to Reuters. The news comes roughly a month after another report from the outlet suggesting that the wearables maker had brought on investment firm Qatalyst Partners to explore a potential sale, in which Alphabet was name dropped as a potential...
Propeller Health’s digital respiratory health platform will be making a bigger splash among European patients thanks to a partnership announced yesterday with Finnish pharmaceuticals and diagnostics company Orion Corporation.
Starting in 2019, the companies will begin co-development of a custom-built Propeller sensor for Orion’s Easyhaler line of inhaled pulmonary drugs. These new sensors will...
In light of its recent CE Mark, Kraków, Poland-based respiratory health company FindAir will begin sales of its digital inhaler add-on to European consumers tomorrow, the company announced in a press release.
The FindAir One device wirelessly connects to an accompanying mobile and web app for patients and doctors alike.
For the former, the app passively collects data with each use to monitor the...
Jerusalem-based Teva Pharmaceuticals’ sensor-packed, app-connected digital inhaler has recently received marketing approval from the US FDA, according to a release from the company. The device will first become available next year through a “small number” of healthcare system pilot partnerships, with a full national launch currently planned for 2020.
Teva’s ProAir Digihaler is indicated for the...
